BNTX

#528
BioNTech SE American Depositary Share
98.41 USD
+1.77%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
98.41
98.41
Rango anual
79.52
123.98
Cambio diario
+1.77%
Variación mensual
+6.97%
Variación en los últimos 6 meses
-3.97%
Cambio anual
-3.79%
Cierres anteriores
96.70
Abrir
98.41
Bid
Ask
Mínimo
98.41
High
98.41
Volumen
118
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

Noticias